Return On Equity in % of REGENEREX PHARMA, INC. from Q3 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
REGENEREX PHARMA, INC. quarterly/annual Return On Equity history and change rate from Q3 2014 to Q3 2025.
  • REGENEREX PHARMA, INC. Return On Equity for the quarter ending 30 Sep 2025 was 69.4 %, a 117% increase year-over-year.
  • REGENEREX PHARMA, INC. annual Return On Equity for 2024 was 79.9 %, a 76.1% decline from 2023.
  • REGENEREX PHARMA, INC. annual Return On Equity for 2023 was 335 %, a 2151% increase from 2022.
  • REGENEREX PHARMA, INC. annual Return On Equity for 2022 was 14.9 %, a 54.5% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

REGENEREX PHARMA, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 69.4 +37.5 +117% 01 Jul 2025 30 Sep 2025
Q2 2025 63 -28.4 -31.1% 01 Apr 2025 30 Jun 2025
Q1 2025 55.3 -56.7 -50.6% 01 Jan 2025 31 Mar 2025
Q4 2024 31 -105 -77.2% 01 Oct 2024 31 Dec 2024
Q3 2024 32 -146 -82.1% 01 Jul 2024 30 Sep 2024
Q2 2024 91.4 +63.6 +229% 01 Apr 2024 30 Jun 2024
Q1 2024 112 +99 +764% 01 Jan 2024 31 Mar 2024
Q4 2023 136 +122 +897% 01 Oct 2023 31 Dec 2023
Q3 2023 178 +161 +941% 01 Jul 2023 30 Sep 2023
Q2 2023 27.8 +8.53 +44.2% 01 Apr 2023 30 Jun 2023
Q1 2023 13 -8.21 -38.8% 01 Jan 2023 31 Mar 2023
Q4 2022 13.6 -35.1 -72% 01 Oct 2022 31 Dec 2022
Q3 2022 17.1 -31.8 -65% 01 Jul 2022 30 Sep 2022
Q2 2022 19.3 -35.3 -64.6% 01 Apr 2022 30 Jun 2022
Q1 2022 21.2 -37.9 -64.2% 01 Jan 2022 31 Mar 2022
Q4 2021 48.7 +71 01 Oct 2021 31 Dec 2021
Q3 2021 48.9 +75.2 01 Jul 2021 30 Sep 2021
Q2 2021 54.5 +83.8 01 Apr 2021 30 Jun 2021
Q1 2021 59.1 +84.7 01 Jan 2021 31 Mar 2021
Q4 2020 -22.3 -43.8 -204% 01 Oct 2020 31 Dec 2020
Q3 2020 -26.3 -57.6 -184% 01 Jul 2020 30 Sep 2020
Q2 2020 -29.2 -58.4 -200% 01 Apr 2020 30 Jun 2020
Q1 2020 -25.6 -52.2 -196% 01 Jan 2020 31 Mar 2020
Q4 2019 21.5 -5.34 -19.9% 01 Oct 2019 31 Dec 2019
Q3 2019 31.3 +16.8 +116% 01 Jul 2019 30 Sep 2019
Q2 2019 29.2 +13.3 +83.4% 01 Apr 2019 30 Jun 2019
Q1 2019 26.6 +10.6 +66.6% 01 Jan 2019 31 Mar 2019
Q4 2018 26.8 +12.8 +90.5% 01 Oct 2018 31 Dec 2018
Q3 2018 14.5 01 Jul 2018 30 Sep 2018
Q2 2018 15.9 01 Apr 2018 30 Jun 2018
Q1 2018 16 01 Jan 2018 31 Mar 2018
Q4 2017 14.1 01 Oct 2017 31 Dec 2017
Q4 2014 -84 01 Sep 2014 30 Nov 2014
Q3 2014 -52.6 01 Jun 2014 31 Aug 2014

REGENEREX PHARMA, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 79.9 -255 -76.1% 01 Apr 2024 31 Mar 2025
2023 335 +320 +2151% 01 Apr 2023 31 Mar 2024
2022 14.9 -17.8 -54.5% 01 Apr 2022 31 Mar 2023
2021 32.7 -48.4 -59.7% 01 Apr 2021 31 Mar 2022
2020 81.1 +113 01 Apr 2020 31 Mar 2021
2019 -31.7 -61.8 -205% 01 Apr 2019 31 Mar 2020
2018 30.1 01 Apr 2018 31 Mar 2019
2014 -84 01 Dec 2013 30 Nov 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.